Precision
Nicholas Bernstein is an experienced finance professional currently serving as Vice President of Corporate Development at Precision Neuroscience, where responsibilities include advising on the acquisition of a leading medical device foundry. Prior to this role, Bernstein operated as a Strategic Financial Advisor at Center Brook, focusing on M&A, capital-raising, and strategic growth for founder- and owner-led companies. Prior experience includes positions at Nomura as Vice President in Private Credit, concentrating on special situations financings, and at Lazard as Vice President in Restructuring, providing strategic financial advice to distressed companies. Bernstein began the career as a Summer Associate at Davis Polk & Wardwell LLP after earning a B.A. in Philosophy from Yale University and a J.D. from New York University School of Law.
This person is not in any teams
This person is not in any offices
Precision
1 followers
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from neurological illnesses. They are building the only brain–computer interface that is designed to be minimally invasive, safely removable, and capable of processing large amounts of data.